Navigation Links
d’Oliveira & Associates Issues Webpage With Current Information On Stryker Hip Implant Lawsuits
Date:1/17/2013

(PRWEB) January 17, 2013

The Food and Drug Administration (FDA) approved Stryker’s first hip implant device for sale on the market in 2003 and approved Styrker’s Rejuvenate Modular and ABG II models in 2008 and 2009 respectively. The Styker hip implant is a medical device where a metal ball connects to a metal socket to simulate the hip joint. Allegedly the metal on metal joint is corrosive and creates health problems for the patient. Serious side effects of the Stryker hip implant allegedly include pain, infection, tissue damage, bone damage, difficulty walking, broken implants, and death. The main cause of these side effects is the corrosion of metal in the body causing the device to fail and resulting in blood toxicity. The alleged failure of the Stryker hip implant has forced patients to undergo corrective surgery. The FDA has issued numerous warnings to Stryker about its packaging, cleanliness, and unsatisfactory manufacturing of its medical devices. In July 2012, Stryker issued a voluntary recall of its hip implant products, Rejuvenate Modular and ABG II. The recall warned of the two products likelihood to fail.

Stryker Lawsuits

Recently, a New York judge denied Stryker’s motion to dismiss based on the statute of limitations. Stryker claimed that the three-year statute of limitations began to run in 2007 when the plaintiff first complained of hip pain. The judge ruled that the jury could find the statute of limitations began to run in 2009 when the plaintiff’s pain escalated. This case illustrates the importance of filing a legal claim in a timely manner because a plaintiff may be barred from recovery if the statute of limitations has expired. (Cerqua, et ux. v. Stryker Corp., et al., No. 11-cv-9208 [KBF] [S.D. N.Y.]) d’Oliveira & Associates has the legal expertise to evaluate your legal claim. On October 18, 2012, ten New Jersey plaintiffs moved to have their claims consolidated in New Jersey state court. Stryker lawsuits claim negligence and strict liability. Specifically, they assert defective product and failure to warn claims.

Do You Have A Stryker Claim?

If you believe that you or one of your loved ones have been injured by a Stryker hip implant, you may want to speak with a personal injury lawyer regarding a medical device claim. A Stryker lawyer familiar with new developments in the investigation of the Stryker hip implant medical device may be able to help you make important personal and legal decisions. d'Oliveira & Associates, P.C. is working with some of the leading medical device lawyers and defective device lawyers in the country who are handling these cases.

Please contact the law offices of d'Oliveira & Associates, P.C. at 1-800-992-6878 or fill out a contact form for a free legal consultation.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10293002.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Research shows efficacy of treatment model developed at Women & Infants
2. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
3. Vendors in Nevada, Michigan, & Illinois to be Featured on the PartyPOP.com Online Network
4. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
5. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
6. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
7. Play & Park Structures Included in New Play for All Abilities Playground
8. Gum Disease, HPV May Play Role in Head & Neck Cancers
9. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
10. Version 2.0 of Award-Winning Proloquo2Go App for iPhone, iPad & iPod touch Speeds Up Communication, Adds New Voices and Customization Options
11. Ear, Nose & Throat Journal publishes research on breakthrough treatment for tonsil stones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology: